Trastuzumab Rezetecan in Advanced Solid Tumors Refractory to Standard Therapies

Abroad (travel likely)RecruitingPHASE2

Conditions

Urachal Cancer · Advanced Solid Tumor Cancer · Antibody-drug Conjugates

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (Sheng ZHANG) · wozhangsheng@hotmail.com · 021-64175590

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Agnostic Therapy in Rare Solid Tumors

Urachal Cancer · Parathyroid Carcinoma · Fibrolamellar Carcinoma

Abroad (travel likely)RecruitingPHASE2

Fortaleza, Brazil · Salvador, Brazil

Ivonescimab in the Treatment of Multiple Advanced Tumors

Pheochromocytoma/Paraganglioma · Rhabdomyosarcoma · Paget Disease, Extramammary

Abroad (travel likely)RecruitingPHASE2

Shanghai, China

Multi-cohort, Single-arm Phase II Study of Albumin-paclitaxel, Ifosfamide, and Cisplatin in the Treatment of Rare Advanced Tumors

Paget Disease, Extramammary · Rhabdomyosarcoma · Testicular Cancer

Abroad (travel likely)RecruitingPHASE2

Shanghai, China